{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:48:01Z","timestamp":1758991681101,"version":"3.37.3"},"reference-count":39,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Indiana School of Medicine","award":["P30 AR072581"],"award-info":[{"award-number":["P30 AR072581"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Autosomal dominant osteopetrosis (ADO) is a rare sclerotic bone disease characterized by impaired osteoclast activity, resulting in high bone mineral density and skeletal fragility. The full phenotype and disease burden on patients\u2019 daily lives has not been systematically measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We developed an online registry to ascertain population-based data on the spectrum and rate of progression of disease and to identify relevant patient-centered outcomes that could be used to measure treatment effects and guide the design of future clinical trials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Cross-sectional data from participants with osteopetrosis were collected using an online REDCap-based database. Thirty-four participants with a confirmed diagnosis of ADO, aged 4-84 years were included. Participants aged 18 years and older completed the PROMIS 57, participants aged 8-17 years completed the PROMIS Pediatric 49, and parents of participants aged &amp;lt;18 years completed the PROMIS Parent Proxy 49.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Based on the PROMIS 57, relative to the general population, adults with ADO reported low physical function and low ability to participate in social roles and activities, and high levels of anxiety, fatigue, sleep problems, and pain interference. Daily pain medications were reported by 24% of the adult population. In contrast, neither pediatric participants nor their parent proxy reported a negative impact on health-related quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Data from this registry demonstrate the broad spectrum of ADO disease severity and high impact on health-related quality of life in adults with ADO.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae285","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:44:04Z","timestamp":1714045444000},"page":"e607-e614","source":"Crossref","is-referenced-by-count":1,"title":["Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2881-6138","authenticated-orcid":false,"given":"Lynda E","family":"Polgreen","sequence":"first","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center , Torrance, CA 90502 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Villa-Lopez","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center , Torrance, CA 90502 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Chen","sequence":"additional","affiliation":[{"name":"The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center , Torrance, CA 90502 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Parks-Schenck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik A","family":"Imel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]},{"name":"Department of Pediatrics, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Econs","sequence":"additional","affiliation":[{"name":"Department of Medicine, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]},{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine , Indianapolis, IA 46202 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"27","key":"2025021815514992900_dgae285-B1","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","article-title":"Osteopetrosis","volume":"351","author":"Tolar","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"2025021815514992900_dgae285-B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/8756-3282(88)90021-X","article-title":"Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis","volume":"9","author":"Bollerslev","year":"1988","journal-title":"Bone"},{"issue":"8","key":"2025021815514992900_dgae285-B3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1359\/jbmr.2003.18.8.1513","article-title":"Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II","volume":"18","author":"Waguespack","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"25","key":"2025021815514992900_dgae285-B4","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","article-title":"Albers-Sch\u00f6nberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene","volume":"10","author":"Cleiren","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2025021815514992900_dgae285-B5","first-page":"365","article-title":"Rntgenbilder einer seltenen knochenkrankung","volume":"51","author":"Albers-Schonberg","year":"1904","journal-title":"Munchen Med Wochenschr"},{"issue":"9","key":"2025021815514992900_dgae285-B6","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group","volume":"102","author":"Wu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021815514992900_dgae285-B7","doi-asserted-by":"crossref","first-page":"116560","DOI":"10.1016\/j.bone.2022.116560","article-title":"Imaging in osteopetrosis","volume":"165","author":"Calder","year":"2022","journal-title":"Bone"},{"issue":"3","key":"2025021815514992900_dgae285-B8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","article-title":"Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation","volume":"92","author":"Waguespack","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021815514992900_dgae285-B9","doi-asserted-by":"crossref","first-page":"116723","DOI":"10.1016\/j.bone.2023.116723","article-title":"Autosomal dominant osteopetrosis","volume":"170","author":"Polgreen","year":"2023","journal-title":"Bone"},{"issue":"6","key":"2025021815514992900_dgae285-B10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bone.2008.07.249","article-title":"CLCN7 polymorphisms and bone mineral density in healthy premenopausal white women and in white men","volume":"43","author":"Chu","year":"2008","journal-title":"Bone"},{"issue":"3","key":"2025021815514992900_dgae285-B11","first-page":"1047","article-title":"Locus heterogeneity of autosomal dominant osteopetrosis (ADO)","volume":"84","author":"White","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025021815514992900_dgae285-B12","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025021815514992900_dgae285-B13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025021815514992900_dgae285-B14","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"2025021815514992900_dgae285-B15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jbi.2012.10.006","article-title":"Procurement of shared data instruments for research electronic data capture (REDCap)","volume":"46","author":"Obeid","year":"2013","journal-title":"J Biomed Inform"},{"issue":"10","key":"2025021815514992900_dgae285-B16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s11136-014-0732-6","article-title":"Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment","volume":"23","author":"Cella","year":"2014","journal-title":"Qual Life Res"},{"issue":"12","key":"2025021815514992900_dgae285-B17","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s11136-019-02261-2","article-title":"Establishing clinically-relevant terms and severity thresholds for patient-reported outcomes measurement information system\u00ae (PROMIS\u00ae) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting","volume":"28","author":"Rothrock","year":"2019","journal-title":"Qual Life Res"},{"issue":"9","key":"2025021815514992900_dgae285-B18","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/rheumatology\/keab014","article-title":"Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking","volume":"60","author":"Bingham","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2025021815514992900_dgae285-B19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11136-017-1709-z","article-title":"Establishing clinical severity for PROMIS\u00ae measures in adult patients with rheumatic diseases","volume":"27","author":"Nagaraja","year":"2018","journal-title":"Qual Life Res"},{"issue":"3","key":"2025021815514992900_dgae285-B20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11136-016-1468-2","article-title":"Establishing clinical meaning and defining important differences for patient-reported outcomes measurement information system (PROMIS\u00ae) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers","volume":"26","author":"Morgan","year":"2017","journal-title":"Qual Life Res"},{"issue":"9","key":"2025021815514992900_dgae285-B21","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s11136-020-02513-6","article-title":"Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus","volume":"29","author":"Mann","year":"2020","journal-title":"Qual Life Res"},{"key":"2025021815514992900_dgae285-B22","doi-asserted-by":"crossref","first-page":"116635","DOI":"10.1016\/j.bone.2022.116635","article-title":"Osteopetrosis: the patient point of view and medical challenges","volume":"167","author":"Cohen-Solal","year":"2023","journal-title":"Bone"},{"key":"2025021815514992900_dgae285-B23","doi-asserted-by":"crossref","first-page":"819641","DOI":"10.3389\/fendo.2022.819641","article-title":"Natural history of type II autosomal dominant osteopetrosis: a single center retrospective study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2025021815514992900_dgae285-B24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/jbmr.3715","article-title":"Interferon gamma-1b does not increase markers of bone resorption in autosomal dominant osteopetrosis","volume":"34","author":"Imel","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025021815514992900_dgae285-B25","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1172\/JCI121561","article-title":"Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain","volume":"129","author":"Zhu","year":"2019","journal-title":"J Clin Invest"},{"issue":"5","key":"2025021815514992900_dgae285-B26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2006.04.033","article-title":"Osteoclasts play a part in pain due to the inflammation adjacent to bone","volume":"39","author":"Nagae","year":"2006","journal-title":"Bone"},{"issue":"1","key":"2025021815514992900_dgae285-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-022-00217-w","article-title":"Mechanisms of bone pain: progress in research from bench to bedside","volume":"10","author":"Zhen","year":"2022","journal-title":"Bone Res"},{"issue":"1","key":"2025021815514992900_dgae285-B28","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.2741\/3585","article-title":"Depression and pain","volume":"14","author":"Robinson","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"2025021815514992900_dgae285-B29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12955-017-0661-5","article-title":"Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS\u00ae to ASCQ-MeSM","volume":"15","author":"Keller","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"2025021815514992900_dgae285-B30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00005792-196803000-00004","article-title":"A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form","volume":"47","author":"Johnston","year":"1968","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2025021815514992900_dgae285-B31","doi-asserted-by":"crossref","first-page":"e10597","DOI":"10.1002\/jbm4.10597","article-title":"Open-label pilot study of interferon gamma\u20131b in patients with non-infantile osteopetrosis","volume":"6","author":"Nguyen","year":"2022","journal-title":"JBMR Plus"},{"issue":"11","key":"2025021815514992900_dgae285-B32","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/jbmr.130","article-title":"Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Sch\u00f6nberg disease (chloride channel 7 deficiency osteopetrosis) among the sclerosing bone disorders","volume":"25","author":"Whyte","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025021815514992900_dgae285-B33","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jbmr.5650111010","article-title":"Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders","volume":"11","author":"Whyte","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025021815514992900_dgae285-B34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2025021815514992900_dgae285-B35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ajmg.a.37537","article-title":"Novel features of 3q29 deletion syndrome: results from the 3q29 registry","volume":"170","author":"Glassford","year":"2016","journal-title":"Am J Med Genet A"},{"volume-title":"Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups","year":"2022","author":"National Academies of Sciences, Engineering and Medicine; Policy and Global Affairs; Committee on Women in Science, Engineering and Medicine; Commitee on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research","key":"2025021815514992900_dgae285-B36"},{"issue":"10","key":"2025021815514992900_dgae285-B37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1359\/jbmr.2000.15.10.1900","article-title":"Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis","volume":"15","author":"B\u00e9nichou","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025021815514992900_dgae285-B38","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"issue":"1","key":"2025021815514992900_dgae285-B39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13023-023-02620-w","article-title":"Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK","volume":"18","author":"Cole","year":"2023","journal-title":"Orphanet J Rare Dis"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae285\/57570023\/dgae285.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/e607\/57570023\/dgae285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/e607\/57570023\/dgae285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:16:00Z","timestamp":1739895360000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/3\/e607\/7657871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,25]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae285","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"type":"print","value":"0021-972X"},{"type":"electronic","value":"1945-7197"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,4,25]]}}}